Cargando…

Fungal infections in adult patients on extracorporeal life support

BACKGROUND: Patients on extracorporeal membrane oxygenation (ECMO) are often among the most severely ill in the intensive care unit. They are often receiving broad-spectrum antibiotics; they have multiple entry points for pathogens; and their immune system is impaired by blood circuit interaction. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavayas, Yiorgos Alexandros, Yusuff, Hakeem, Porter, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905180/
https://www.ncbi.nlm.nih.gov/pubmed/29665838
http://dx.doi.org/10.1186/s13054-018-2023-z
_version_ 1783315225048514560
author Cavayas, Yiorgos Alexandros
Yusuff, Hakeem
Porter, Richard
author_facet Cavayas, Yiorgos Alexandros
Yusuff, Hakeem
Porter, Richard
author_sort Cavayas, Yiorgos Alexandros
collection PubMed
description BACKGROUND: Patients on extracorporeal membrane oxygenation (ECMO) are often among the most severely ill in the intensive care unit. They are often receiving broad-spectrum antibiotics; they have multiple entry points for pathogens; and their immune system is impaired by blood circuit interaction. These factors are thought to predispose them to fungal infections. We thus aimed to evaluate the prevalence, risk factors, and prognosis of fungal infections in adults on ECMO. METHODS: We conducted a retrospective cohort study using the Extracorporeal Life Support Organization registry, which compiles data on ECMO use from hundreds of international centers. We included all adult patients from 2006 to 2016 on any mode of ECMO with either a diagnosis of fungal infection or a positive fungal culture. RESULTS: Our study comprised 2129 adult patients (10.8%) with fungal colonization or infection. Aspergillus involvement (colonization or infection) was present in 272 patients (1.4%), of whom 35.7% survived to hospital discharge. There were 245 patients (1.2%) with Candida invasive bloodstream infection, with 35.9% survival. Risk factors for Aspergillus involvement included solid organ transplant (OR 1.83; p = 0.008), respiratory support (OR 2.75; p < 0.001), and influenza infection (OR 2.48; p < 0.001). Risk factors for candidemia included sepsis (OR 1.60; p = 0.005) and renal replacement therapy (OR 1.55; p = 0.007). In multivariable analysis, Aspergillus involvement (OR 0.40; p < 0.001) and candidemia (OR 0.47; p < 0.001) were both independently associated with decreased survival. CONCLUSIONS: The prevalence of Aspergillus involvement and Candida invasive bloodstream infection were not higher in patients on ECMO than what has been reported in the general intensive care population. Both were independently associated with a reduced survival. Aspergillus involvement was strongly associated with ECMO for respiratory support and influenza. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-018-2023-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5905180
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59051802018-04-24 Fungal infections in adult patients on extracorporeal life support Cavayas, Yiorgos Alexandros Yusuff, Hakeem Porter, Richard Crit Care Research BACKGROUND: Patients on extracorporeal membrane oxygenation (ECMO) are often among the most severely ill in the intensive care unit. They are often receiving broad-spectrum antibiotics; they have multiple entry points for pathogens; and their immune system is impaired by blood circuit interaction. These factors are thought to predispose them to fungal infections. We thus aimed to evaluate the prevalence, risk factors, and prognosis of fungal infections in adults on ECMO. METHODS: We conducted a retrospective cohort study using the Extracorporeal Life Support Organization registry, which compiles data on ECMO use from hundreds of international centers. We included all adult patients from 2006 to 2016 on any mode of ECMO with either a diagnosis of fungal infection or a positive fungal culture. RESULTS: Our study comprised 2129 adult patients (10.8%) with fungal colonization or infection. Aspergillus involvement (colonization or infection) was present in 272 patients (1.4%), of whom 35.7% survived to hospital discharge. There were 245 patients (1.2%) with Candida invasive bloodstream infection, with 35.9% survival. Risk factors for Aspergillus involvement included solid organ transplant (OR 1.83; p = 0.008), respiratory support (OR 2.75; p < 0.001), and influenza infection (OR 2.48; p < 0.001). Risk factors for candidemia included sepsis (OR 1.60; p = 0.005) and renal replacement therapy (OR 1.55; p = 0.007). In multivariable analysis, Aspergillus involvement (OR 0.40; p < 0.001) and candidemia (OR 0.47; p < 0.001) were both independently associated with decreased survival. CONCLUSIONS: The prevalence of Aspergillus involvement and Candida invasive bloodstream infection were not higher in patients on ECMO than what has been reported in the general intensive care population. Both were independently associated with a reduced survival. Aspergillus involvement was strongly associated with ECMO for respiratory support and influenza. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-018-2023-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-17 /pmc/articles/PMC5905180/ /pubmed/29665838 http://dx.doi.org/10.1186/s13054-018-2023-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Cavayas, Yiorgos Alexandros
Yusuff, Hakeem
Porter, Richard
Fungal infections in adult patients on extracorporeal life support
title Fungal infections in adult patients on extracorporeal life support
title_full Fungal infections in adult patients on extracorporeal life support
title_fullStr Fungal infections in adult patients on extracorporeal life support
title_full_unstemmed Fungal infections in adult patients on extracorporeal life support
title_short Fungal infections in adult patients on extracorporeal life support
title_sort fungal infections in adult patients on extracorporeal life support
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905180/
https://www.ncbi.nlm.nih.gov/pubmed/29665838
http://dx.doi.org/10.1186/s13054-018-2023-z
work_keys_str_mv AT cavayasyiorgosalexandros fungalinfectionsinadultpatientsonextracorporeallifesupport
AT yusuffhakeem fungalinfectionsinadultpatientsonextracorporeallifesupport
AT porterrichard fungalinfectionsinadultpatientsonextracorporeallifesupport